Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?When is tenofovir alafenamide patent expiring?Diltiazem drug class?Dabrafenib and trametinib price?Pramlintide approval date?
See the DrugPatentWatch profile for Kesimpta
Kesimpta (ofatumumab) received FDA approval on August 14, 2020. [1]
That approval covered Kesimpta for the treatment of relapsing forms of multiple sclerosis. [1]
1
Other Questions About Kesimpta :